Tai Chi for Parkinson's (NCT07662837)
See which exercise improves balance
- Trial ID
- NCT07662837
- Official Title
- Effects of Tai Chi Therapy Versus Qi-Gong on Postural Control, Functional Balance , and Motor Function in Stage-I Parkinson's Patients.
- Goal
- See which exercise improves balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Lahore University of Biological and Applied Sciences
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- PARKINSON DISEASE (Disorder)
- Interventions
- Tai Chi, Qi Gong
Summary For Families
Researchers are comparing Tai Chi and Qi-Gong to see which movement therapy better improves posture, balance, and overall movement in people with early, Stage I Parkinson's, and which one people are more likely to keep doing. Participants are randomly assigned to one of the two programs for about 8 to 12 weeks, with measurements taken before and after using standard tools like the Unified Parkinson's Disease Rating Scale and the Berg Balance Scale. The study also looks at patient-centered outcomes such as how people perceive the exercise to help guide practical physiotherapy choices. Adults aged 50 to 65 with Stage I Parkinson's who have been on a stable Parkinson's medication dose for at least three months, can do basic self-care, and have no significant cognitive problems are eligible; people with significant depression, recent deep brain stimulation, certain medications that affect thinking or alertness, or who are already in an exercise program are excluded.
Locations
- Ghurki Trust and Teaching Hospital, Lahore, Punjab Province, Pakistan
- The Meer's Physiotherapy and Rehabilitation, Lahore, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Tai Chi. Researchers are comparing Tai Chi and Qi-Gong to see which movement therapy better improves posture, balance, and overall movement in people with early, Stage I Parkinson's, and which one people are more likely to keep doing. Participants are randomly assigned to one of the two programs for about 8 to 12 weeks, with measurements taken before and after using standard tools like the Unified Parkinson's Disease Rating Scale and the Berg Balance Scale. The study also looks at patient-centered outcomes such as how people perceive the exercise to help guide practical physiotherapy choices. Adults aged 50 to 65 with Stage I Parkinson's who have been on a stable Parkinson's medication dose for at least three months, can do basic self-care, and have no significant cognitive problems are eligible; people with significant depression, recent deep brain stimulation, certain medications that affect thinking or alertness, or who are already in an exercise program are excluded.
- Who can participate?
- Participants must be between 50 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- Assessments are recorded at baseline and post-intervention, and the study lasts 8 to 12 weeks.